The SELECT Trial has revealed the potential of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in combating kidney function decline among individuals with overweight or obesity and ...

Medically reviewed by Alex Yampolsky, PharmD Key Takeaways ACE inhibitors lower blood pressure and protect the kidneys by ...

A recent study found that semaglutide may help reduce the progression of kidney disease in people with type 2 diabetes. A new study from researchers at the University of Edinburgh, in the United ...

The study covered in this summary was published in Research Square as a preprint and has not yet been peer reviewed. Nearly two thirds of Brazilian study participants with childhood-onset type 1 ...

The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without ...

Medications and extra fluid infusions can help protect your kidneys from damage during chemotherapy. More than one million people receive chemotherapy or radiation treatments for their cancer each ...

Micurx Pharmaceuticals Inc. has patented peptide-drug conjugates consisting of peptide targeting kidney cells covalently linked to an anti-inflammatory or immunomodulating or nephron-protective drug ...

A molecule made by bacteria in the gut can hitch a ride to the kidneys, where it sets off a chain reaction of inflammation, scarring and fibrosis - a serious complication of diabetes and a leading ...

Your kidneys work around the clock filtering about 200 quarts of blood daily, removing waste products, balancing electrolytes, and producing hormones that regulate blood pressure. These bean-shaped ...

CHICAGO (Reuters) - A drug used to protect the kidneys from contrast dye during X-rays of the heart's blood vessels does not work, researchers said on Tuesday, citing a large study that may change the ...